- Home
- BKE vs BCRX Comparison
BKE vs BCRX Comparison
Compare BKE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | BCRX |
|---|---|---|
| Founded | 1948 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BKE | BCRX |
|---|---|---|
| Price | $46.43 | $8.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $20.55 |
| AVG Volume (30 Days) | 342.7K | ★ 4.5M |
| Earning Date | 11-20-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | 6.43 | ★ 381.40 |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $1,297,835,000.00 | $25,186,000.00 |
| Revenue This Year | $5.47 | N/A |
| Revenue Next Year | $3.97 | $3.71 |
| P/E Ratio | $26.47 | ★ N/A |
| Revenue Growth | ★ 6.58 | N/A |
| 52 Week Low | $39.44 | $6.23 |
| 52 Week High | $58.52 | $11.22 |
Technical Indicators
Market Signals| Indicator | BKE | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.50 | 50.70 |
| Support Level | $46.80 | $8.09 |
| Resistance Level | $47.53 | $9.22 |
| Average True Range (ATR) | 1.12 | 0.28 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 69.05 | 70.18 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.